From an immunological standpoint, methylation directly regulates immune checkpoint expression: PD-L1 promoter hypomethylation has been linked to its overexpression in gliomas, enabling tumor cells to evade T cell-mediated killing (24). The gene discussed is CD274; the disease is neoplasm.